Hyderabad: Investments in global capability centres (GCCs) by US-based AI and data science company Tredence Inc, and the expansion of its GCC by French consumer healthcare player Opella Healthcare, along with new vaccine manufacturing facilities by Indonesian animal vaccines maker Vaksindo Animal Health and a Rs 1,000 crore investment by Rx Propellant in setting up advanced laboratory infrastructure, were announced at the inauguration of BioAsia 2026 here.
On the other hand, Vaksindo, which is a division of Indonesia’s JAPFA, will be setting up a BSL-3 vaccine manufacturing facility in Genome Valley to produce vaccines for poultry, cattle, swine and aquaculture.
The inaugural session, conducted on the theme, “TechBio Unleashed: AI, Automation, and the Biology Revolution”, also saw Prof Bruce L Levine of the University of Pennsylvania being awarded the Genome Valley Excellence Award for his contributions to cancer gene therapy.